News & Perspective

Oct 11, 2019

Oct 11, 2019

ASP Scan (Weekly) for Oct 11, 2019

Probiotics and C diff risk
MCR genes on Algerian farms
Price cut demand for MDR-TB drug
ICU infections in Europe
XDR typhoid in travelers
Post-hospital antibiotic use
Resistant gonorrhea response plan
Urinary antigen testing for pneumonia
C diff testing guidelines challenged
XDR Klebsiella pneumoniae

Sep 13, 2019

Sep 13, 2019

ASP Scan (Weekly) for Sep 13, 2019

India joins antibiotic R&D hub
Resistant infections in African infants
Antibiotics in UK poultry
Chick-fil-A antibiotic-free
Resistant E coli in sewage
Fluoroquinolones and leaky heart valves
Meropenem for bacterial meningitis
Antibiotics and flu vaccine response
Treating complex abdominal infection

Sep 06, 2019

Sep 06, 2019

ASP Scan (Weekly) for Sep 06, 2019

Resistance rates and income
Assessing national stewardship programs
Antibiotics on citrus trees
Telehealth-based stewardship
Pharmacist-led outpatient stewardship
VRE risks in C diff treatment
Cultural influence on prescribing
Group A strep vaccine candidate
Value of pre-op urine tests
Stewardship training for medical residents

Mar 22, 2019

Mar 22, 2019

ASP Scan (Weekly) for Mar 22, 2019

New asymptomatic bacteriuria guidance
Resistant Enterococcus in wastewater
Stewardship in pet care
Fewer antibiotics in Salmon
Gloves, gowns, and MDROs
WHO drug-resistant TB guidelines
Antibiotic development partnership
Lung disease bacteria in tap water
Drop in US prescribing
Short course for Pseudomonas
Antibiotic cardiac device 'envelope'

Feb 01, 2019

Feb 01, 2019

ASP Scan (Weekly) for Feb 01, 2019

Animal stewardship partnership
Antibiotic pipeline details
New PACCARB members
Decline in UK antibiotics
Superbug bloodstream infections in Greece
Antibiotics and malaria prevention
Promising antifungal candidate
Proposed UN AMR guidance
Proposed UN AMR guidance
Antibiotic use in nursing homes
Novel antibiotic vs C diff
Pharmacist interventions
Antibiotics for asthma attack

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»